Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Prism Pharma Co., Ltd.
Sponsor:
Collaborator:
inVentiv Health Clinical
Information provided by (Responsible Party):
Prism Pharma Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01606579
First received: May 16, 2012
Last updated: April 28, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)